Delivery Order SPE2DB20D7059-SPE2DB24FQEG1
- Not listed
- This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $1,645.62 and is a Firm Fixed Price Delivery Order that runs through May 1, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
- The U.S. government's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order contract worth $12,850.04 for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,970.80 firm-fixed-price delivery order is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a completion date of June 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA...
- This federal contract award, valued at $2,194.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of May 7, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a...
- This federal contract award was granted to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, with a ceiling value of $2,697.62, is a Delivery Order from the Defense Logistics Agency (DLA), a defense agency, for the delivery of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 23, 2024....
- The federal contract award is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, awarded to prime contractor Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $6,514.83 firm fixed-price delivery order has a completion date of November 20, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor registered in the System for Award Management (SAM.gov), with a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
- This federal contract award is for the delivery of the prescription medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $12,166.79 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the prescription medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $2,942.47 and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an extensive Indefinite Delivery Contract (IDC) with the DLA Troop...
- The federal contract award is for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The delivery order has a ceiling value of $1,555.60 and a period of performance through May 9, 2025. This contract is not set-aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $6,488.12 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA,...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQEG1Delivery Order
This federal contract award is for the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract has a ceiling value of $6,502.28 and is a Firm Fixed Price Delivery Order that runs through April 30, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 4/29/24 |